Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Sara A. Hurvitz, MD, FACP

Advertisement

Articles by Sara A. Hurvitz, MD, FACP

Sara A. Hurvitz MD of Fred Hutch Cancer Center

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer: What Nurses Need to Know

BySara A. Hurvitz, MD, FACP
July 15th 2026

FDA approves gedatolisib for HR+/HER2– breast cancer. Learn about the VIKTORIA-1 trial, dosing, and nursing strategies for managing stomatitis.

Advertisement

Latest Updated Articles

  • Sara A. Hurvitz MD of Fred Hutch Cancer Center
    FDA Approves Gedatolisib for HR+/​HER2- Advanced Breast Cancer: What Nurses Need to Know

    July 15th 2026



Advertisement
Advertisement

Trending on Oncology Nursing News

1

The Role of Oncology Nurse Practitioners in Metastatic Triple-Negative Breast Cancer Care

2

Daraxonrasib Approved: What Oncology Nurses Must Know About Rasonque

3

mRNA Cancer Vaccine Met Endpoints in Adjuvant Melanoma

4

Exercise May Reverse Obesity-Induced Immune Suppression in Lung Cancer

5

APAO 2026: Mark Honor on the Role of PAs as Oncology Care Managers

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us